These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
209 related items for PubMed ID: 4030876
1. A comparison of blood and Fluosol-DA for cardiopulmonary bypass. Rousou JA, Engelman RM, Anisimowicz L, Dobbs WA. J Cardiovasc Surg (Torino); 1985; 26(5):447-53. PubMed ID: 4030876 [Abstract] [Full Text] [Related]
2. Use of Fluosol-DA during open-heart surgery. Engelman RM, Dobbs WA, Rousou JH, Anisimowicz L. Prog Clin Biol Res; 1983; 122():273-82. PubMed ID: 6878370 [Abstract] [Full Text] [Related]
3. Fluosol-DA: an artificial blood for total cardiopulmonary bypass. Engelman RM, Rousou JH, Dobbs WA. Ann Thorac Surg; 1981 Dec; 32(6):528-35. PubMed ID: 7316587 [Abstract] [Full Text] [Related]
4. Short term survival following perfusion with fluosol-DA for cardiopulmonary bypass. Rousou JA, Engelman RM, Breyer RH, Allred C, Forouhar F. Int J Artif Organs; 1985 Sep; 8(5):281-6. PubMed ID: 3936789 [Abstract] [Full Text] [Related]
5. Hemodynamic and oxygen transport effects of a perfluorochemical blood substitute, fluosol-DA (20%). Tremper KK, Lapin R, Levine E, Friedman A, Shoemaker WC. Crit Care Med; 1980 Dec; 8(12):738-41. PubMed ID: 7449405 [Abstract] [Full Text] [Related]
13. The effect of Fluosol-DA on oxygen availability in focal cerebral ischemia. Sutherland GR, Farrar JK, Peerless SJ. Stroke; 1984 Dec; 15(5):829-35. PubMed ID: 6433517 [Abstract] [Full Text] [Related]
14. Clinical experience with Fluosol-DA. Gould SA, Rosen AL, Sehgal LR, Sehgal HL, Moss GS. Prog Clin Biol Res; 1983 Dec; 122():331-42. PubMed ID: 6878375 [Abstract] [Full Text] [Related]
15. Experimental studies on fluosol DA administration in acute pancreatitis. Ohyanagi H, Ohashi O, Nakayama S, Yamamoto M, Okumura S, Saitoh Y. Biomater Artif Cells Artif Organs; 1988 Dec; 16(1-3):585-94. PubMed ID: 3179491 [Abstract] [Full Text] [Related]
16. Maternal and fetal effects of exchange transfusion with a red blood cell substitute. Cefalo RC, Seeds JW, Proctor HJ, Baker VV. Am J Obstet Gynecol; 1984 Apr 01; 148(7):859-67. PubMed ID: 6711627 [Abstract] [Full Text] [Related]
17. [The place for using erythrocyte substitutes in hemodilution: fluosol-DA and polymerized pyridoxylated hemoglobin]. Vigneron C, Labrude P, Dellacherie E. Ann Fr Anesth Reanim; 1986 Apr 01; 5(3):260-8. PubMed ID: 3535579 [Abstract] [Full Text] [Related]